Radical Cystectomy

Introduction

If you or someone you care for is facing radical cystectomy, you are likely in a difficult and uncertain time. The idea of removing the bladder and learning a new way to pass urine raises real questions about safety, recovery, and what daily life will look like afterwards. These questions deserve clear, calm answers.

Radical cystectomy is a major operation, but it is also a well-established one. For people with muscle-invasive bladder cancer or high-risk disease that has not responded to bladder-sparing treatment, it offers one of the strongest chances of long-term cancer control. Modern techniques — including robotic surgery, refined reconstruction methods, and enhanced recovery protocols — have improved safety and recovery times compared with even a decade ago.

This guide explains what radical cystectomy involves, who it is recommended for, the different surgical approaches and urinary diversion options, how to prepare, what recovery looks like, the main risks, and what life is generally like in the months and years after surgery.

What Is Radical Cystectomy?

Radical cystectomy is the surgical removal of the entire urinary bladder, together with nearby tissues and lymph nodes, most often to treat bladder cancer. Because the bladder normally stores urine before it leaves the body, the surgeon also has to build a new route for urine to exit. This second part of the operation is called urinary diversion.

The exact organs removed depend on anatomy and the extent of cancer:

• In men, the operation usually removes the bladder, the prostate, the seminal vesicles, and the pelvic lymph nodes.
• In women, it may remove the bladder, the uterus, the fallopian tubes and ovaries, part of the front wall of the vagina, and the pelvic lymph nodes. In selected cases, surgeons may preserve some of these structures.

You may also hear the term “radical cystoprostatectomy” in men or “anterior pelvic exenteration” in women — these describe the same overall operation with slightly different emphasis on what is removed.

The main goal of the surgery is to remove all of the cancer with clear margins (no cancer cells at the edges of the removed tissue) and to take out the local lymph nodes where bladder cancer is most likely to spread.

Why Is Radical Cystectomy Performed?

Radical cystectomy is most commonly performed for bladder cancer. The situations where major urology societies, including the American Urological Association (AUA), the European Association of Urology (EAU), and the National Comprehensive Cancer Network (NCCN), describe it as a standard treatment include:

• Muscle-invasive bladder cancer — cancer that has grown into the muscle wall of the bladder (stage T2 or higher), without distant spread.
• High-risk non-muscle-invasive bladder cancer that has not responded to treatments such as intravesical BCG (a medication put into the bladder), or that keeps coming back in an aggressive form.
• Certain non-urothelial bladder cancers, such as squamous cell carcinoma, adenocarcinoma, or small cell carcinoma of the bladder, where bladder-sparing options are limited.
• Locally advanced disease where the cancer has spread to nearby tissues but is still considered removable.
• Severe, non-cancer bladder conditions in rare cases — for example, a badly damaged bladder from radiation, severe interstitial cystitis, or extensive bladder trauma — though these are uncommon reasons.

Before recommending surgery, the team usually reviews the cancer’s stage and grade, imaging (CT scan of the chest, abdomen, and pelvis, sometimes MRI or PET-CT), kidney function, and overall fitness. Most large centres discuss these cases in a multidisciplinary tumour board so that urology, oncology, radiology, and pathology specialists agree on the plan together.

Who Is a Candidate?

Being a candidate for radical cystectomy depends on both the cancer and the person.

Cancer-related factors include the tumour stage, whether the cancer is confined to the pelvis, whether lymph nodes look involved on scans, and whether earlier treatments have failed.

Patient-related factors include:

• Overall health and fitness, including heart and lung function
• Kidney function — important because some diversion options depend on having reasonably healthy kidneys
• Nutritional status
• Whether you smoke (stopping before surgery reduces complications)
• Ability to manage a stoma or self-catheterisation, depending on the planned diversion
• Other illnesses such as diabetes or cardiovascular disease that affect recovery

Age alone is not a barrier. Many people in their seventies and even eighties have successful cystectomy when their overall health supports it. What matters more than the date on a birth certificate is functional fitness — how well your body is likely to cope with a long operation and several weeks of recovery.

For people who are not fit enough for major surgery, or who choose to avoid it, doctors may consider alternatives such as combined chemotherapy and radiation (a “trimodal” bladder-preservation approach), which is discussed below.

Alternatives to Radical Cystectomy

Whether an alternative is reasonable depends heavily on the cancer’s stage, grade, and location. The decision is a clinical one made with your urologist and oncologist, but it helps to understand the main options that exist.

Bladder-Preserving Trimodal Therapy

For carefully selected people with muscle-invasive bladder cancer, current AUA and EAU guidelines describe trimodal therapy as a possible alternative to cystectomy. It combines:

1. Maximal transurethral resection of the bladder tumour (TURBT) — removing as much of the visible tumour as possible through the urethra
2. Radiation therapy to the bladder
3. Chemotherapy given alongside radiation to make it work better

Trimodal therapy is most often considered for people with a single tumour, no widespread carcinoma in situ, good bladder function, and no hydronephrosis (swelling of the kidney from blocked urine). It preserves the bladder, but it requires careful lifelong surveillance and a salvage cystectomy if the cancer returns.

Partial Cystectomy

In rare cases — a single, small tumour in a part of the bladder that can be removed with a clear margin, and no widespread cancer in the rest of the bladder — surgeons may remove only the affected portion. Partial cystectomy is uncommon because most bladder cancers are not suitable for it.

Intravesical Therapy and Repeat TURBT

For non-muscle-invasive disease, treatments such as intravesical BCG or chemotherapy delivered directly into the bladder, combined with repeat TURBTs, may control the cancer for a long time. Cystectomy is generally considered when these treatments fail or when high-risk features develop.

Systemic Therapy Alone

When cancer has spread beyond the pelvis, the main treatment shifts to systemic therapy — chemotherapy and increasingly immunotherapy — rather than surgery. Cystectomy may still be considered in some situations to control local symptoms, but it is not the primary treatment.

Major urology societies recommend that the choice between cystectomy and bladder preservation be discussed openly, including the trade-offs in cancer control, quality of life, and lifelong follow-up.

Surgical Approaches

There are three main ways the operation can be performed. The goal of the cancer removal is the same in each; the differences are in how the surgeon reaches the bladder.

Open Radical Cystectomy

This is the traditional approach, performed through a single incision in the lower abdomen. The surgeon has direct access to the pelvis and can feel the tissues by hand. Open surgery remains widely used and is the approach with the longest track record. It is often chosen when the cancer is locally advanced, when previous surgery makes minimally invasive access difficult, or based on the surgeon’s experience.

Laparoscopic Radical Cystectomy

In a laparoscopic approach, the surgeon operates through several small incisions using long instruments and a camera. Compared with open surgery, it generally involves smaller scars and less blood loss. Pure laparoscopic cystectomy is technically demanding, and many centres that offer minimally invasive cystectomy now use the robotic approach instead.

Robotic-Assisted Radical Cystectomy

In robotic surgery, the surgeon controls precise instruments from a console while looking at a magnified, three-dimensional view of the pelvis. Studies suggest robotic cystectomy can offer less blood loss, smaller incisions, and a faster return to normal activities compared with open surgery, while achieving similar cancer-control outcomes when performed in experienced centres. The reconstruction of the urinary diversion may be done either inside the body (“intracorporeal”) or through a small abdominal incision (“extracorporeal”), depending on the surgeon’s practice.

The choice of approach is a clinical decision based on the cancer’s features, your anatomy and previous surgeries, the planned diversion type, and the surgical team’s expertise. Cancer-control outcomes, when surgery is done well, are similar across approaches.

Urinary Diversion Options

Because the bladder is removed, urine needs another route out of the body. The surgeon usually creates this new system from a segment of your own intestine. There are three main types of diversion. The choice depends on the cancer’s location, your kidney and liver function, your ability to manage the day-to-day care of each option, and your preferences.

Ileal Conduit

This is the most common diversion worldwide. The surgeon takes a short segment of the small intestine (the ileum), connects the ureters (the tubes that bring urine from the kidneys) to one end, and brings the other end out through an opening in the abdominal wall called a stoma. Urine drains continuously into a small bag worn on the skin.

An ileal conduit is technically simpler, has a shorter operating time, and works well for many people, including those with reduced kidney function or who prefer not to manage self-catheterisation. The trade-off is the need to wear and care for an external bag.

Neobladder (Orthotopic Neobladder)

A neobladder is an internal pouch built from a longer segment of intestine and connected to the urethra. The ureters drain into the pouch, and urine exits through the natural urethra. After learning new techniques, many people can urinate by relaxing the pelvic floor and pressing gently on the abdomen.

A neobladder allows more natural urination and avoids an external bag. It is generally considered for people with good kidney and liver function, sufficient urethral length and quality, and the motivation and dexterity to learn the new urinary control techniques. Continence often improves over the first year, though some people experience night-time leakage or need to learn intermittent self-catheterisation if the pouch does not empty fully.

Continent Cutaneous Diversion

This option creates an internal pouch from intestine, similar to a neobladder, but instead of connecting to the urethra it is brought to the abdominal skin through a small, continent (non-leaking) channel. The pouch is emptied several times a day by passing a thin catheter through the channel.

It avoids an external bag and offers continence, but it requires the dexterity and willingness to self-catheterise regularly. It may be considered when a neobladder is not suitable — for example, when the cancer affects the urethra.

Your surgical team will discuss which options are realistic in your case. Many centres ask you to meet a stoma nurse and, when relevant, talk with people who have lived with each type of diversion before making a decision.

Preparing for Radical Cystectomy

Preparation usually starts several weeks before the operation and has two aims: confirming the cancer’s stage and getting your body into the best possible shape.

Investigations typically include:

• Cystoscopy and biopsy to confirm the diagnosis
• CT scan of the chest, abdomen, and pelvis
• MRI or PET-CT in selected cases
• Blood tests, including kidney and liver function
• Urine tests
• Heart and lung assessment, especially if you have existing health conditions

Neoadjuvant chemotherapy — chemotherapy given before surgery — is recommended by major guidelines, including AUA, EAU, and NCCN, for many people with muscle-invasive bladder cancer who can tolerate cisplatin-based regimens. Studies have shown it improves survival compared with surgery alone. This adds several weeks or months to the preparation period.

Prehabilitation has become an important part of preparation in many centres. It often includes:

• Stopping smoking as early as possible — smoking significantly increases the risk of wound and lung complications
• Nutrition support, with a focus on adequate protein intake
• Physical conditioning — walking, gentle strength work, and breathing exercises
• Diabetes and blood pressure control
• Stoma site marking by a stoma nurse if a stoma is planned, choosing a position that will work with your body shape and clothing
• Counselling about the diversion choice, including its effect on sexual function, body image, and daily activities

Many centres now follow Enhanced Recovery After Surgery (ERAS) protocols for cystectomy. These structured plans — covering nutrition, fluid management, early mobilisation, and reduced reliance on opioids — have been shown to shorten hospital stay and reduce complications.

What Happens During Surgery

Radical cystectomy is performed under general anaesthesia. The operation usually takes between four and eight hours, depending on the approach, the diversion type, and individual anatomy.

The general sequence is:

1. You are given general anaesthesia and positioned carefully on the operating table.
2. The surgical team makes the incision (open) or places the ports (laparoscopic or robotic).
3. The bladder and the surrounding structures listed earlier are removed.
4. The pelvic lymph nodes are removed and sent for examination — this is an important part of accurate staging.
5. The urinary diversion is constructed using a segment of intestine. The bowel is then reconnected so that food can pass through normally.
6. Drains and catheters are placed to allow fluid and urine to drain in the early days after surgery.
7. The incisions are closed.

You will usually wake up in a recovery area before being moved to an intensive care or high-dependency unit for the first day or two, then to a regular ward.

Recovery and Healing

In the Hospital

A typical hospital stay is around seven to fourteen days, though this varies with the approach used, the diversion type, and your overall progress. During this time the team focuses on:

• Pain control, increasingly without heavy reliance on opioids
• Getting you out of bed and walking as early as possible — often on day one
• Watching for bowel function to return
• Gradually reintroducing fluids and food
• Teaching stoma care (if you have an ileal conduit) or neobladder/self-catheterisation training
• Removing drains and catheters as healing allows

At Home

General milestones include:

• Weeks 1–2: Wound healing, gradually increasing walking, continued stoma or diversion care.
• Weeks 4–6: Many people can resume light, non-strenuous activities. Driving may be possible once you can move comfortably and react quickly — check with your team.
• Weeks 8–12: Energy and strength continue to return. Light exercise becomes easier.
• 3–6 months: Most people feel substantially recovered, though full energy and adaptation to the diversion may take longer.

For people with a neobladder, continence usually improves over the first six to twelve months, often more so during the day than at night. Pelvic floor exercises and a structured voiding schedule are part of this learning process.

Heavy lifting, strenuous exercise, and contact sports are usually avoided for around six to eight weeks to protect the healing abdomen. Your surgical team will give you specific timelines based on the approach used.

Risks and Complications

Radical cystectomy is one of the larger operations in oncology, and complications are not unusual. Knowing about them in advance helps you and your family recognise problems early.

Short-term complications can include:

• Bleeding, sometimes requiring transfusion
• Infection of the wound, urinary tract, or chest
• Blood clots in the legs or lungs
• Slow return of bowel function (ileus) or bowel obstruction
• Leakage from the urinary or bowel join (anastomotic leak)
• Heart, lung, or kidney problems related to major surgery

Longer-term complications can include:

• Stoma problems (skin irritation, hernia around the stoma, narrowing)
• Urinary tract infections, sometimes recurrent
• Narrowing where the ureters join the diversion, which can affect kidney drainage
• Electrolyte and acid-base imbalances, because intestine used in the diversion absorbs some substances from urine
• Vitamin B12 deficiency over time, especially with diversions that use a longer segment of bowel
• Kidney function changes over the years
• Sexual dysfunction — erectile dysfunction in men, and changes in vaginal anatomy and sensation in women
• Changes in body image and psychological adjustment

Nerve-sparing techniques may reduce the risk of erectile dysfunction in selected men, when oncologically safe. Women may discuss organ-sparing approaches with their surgeon where the cancer’s location allows.

Major studies show that complication rates and overall outcomes are better in high-volume centres — hospitals and surgeons that perform many cystectomies each year — than in lower-volume settings. This is one of the reasons specialist uro-oncology centres are often recommended for this surgery.

Adjuvant Treatment After Surgery

The final cancer stage is known only after the pathologist has examined the bladder and lymph nodes. Based on these findings, the oncology team may discuss further treatment.

• Adjuvant chemotherapy may be recommended if higher-risk features are found at surgery and you did not receive chemotherapy beforehand. It is supported by current guidelines in selected situations.
• Adjuvant immunotherapy with checkpoint inhibitors has emerged as an option for some people at higher risk of recurrence after cystectomy, based on recent trial data, and is now reflected in NCCN and EAU recommendations.
• Radiation therapy is used less often after cystectomy but may be considered in specific situations, such as positive surgical margins or particular patterns of local disease.

Whether adjuvant treatment is appropriate, and which type, is a discussion between you, the surgeon, and the medical oncologist, based on the pathology results and your recovery.

Life After Radical Cystectomy

The first months after surgery are usually focused on healing and learning. Beyond that, most people describe gradually finding a new normal — one in which the diversion becomes a familiar part of daily routines rather than the centre of attention.

Living with a Stoma (Ileal Conduit)

People with a stoma learn to change the appliance, manage skin care, and recognise common issues such as leaks or skin irritation. Stoma nurses are an important source of support in the first weeks. Most clothing, swimming, travel, and physical activities are possible. Some people choose specific waistbands or appliances for comfort. Heavy lifting may need to be modified to reduce the risk of a parastomal hernia.

Living with a Neobladder

People with a neobladder learn a new pattern of urination, often timed at intervals to prevent over-stretching. Daytime continence usually improves significantly over the first year. Night-time leakage is common at first and improves more slowly. Some people need to learn intermittent self-catheterisation to fully empty the pouch.

Living with a Continent Cutaneous Diversion

Self-catheterisation through the abdominal channel several times a day becomes routine. There is no external bag, and clothing options are flexible.

Sexual Health and Intimacy

Sexual function is affected by radical cystectomy in both men and women. Many people find this aspect difficult to bring up but important to discuss with the surgical team beforehand and during follow-up. Options for support include:

• Medications and devices for erectile dysfunction
• Pelvic floor therapy and lubricants for vaginal changes
• Counselling, including for partners
• Open conversations about timing, body image, and adjustment

Diet, Hydration, and Daily Habits

Most people return to a normal diet. Adequate hydration is important to keep the diversion working well and reduce the risk of stones and infections. Some people benefit from advice on foods that affect stoma output or urine odour. Vitamin B12 levels are usually monitored over time, since some diversions affect absorption.

Work, Travel, and Exercise

Most people return to work, travel, and exercise. The timing depends on the type of work (desk-based vs physical), the diversion, and personal recovery. Travel with a stoma or neobladder is very feasible with some practical planning — carrying spare supplies, knowing where to access help, and planning regular hydration.

Emotional Adjustment

Adjusting to a new body and a new way of passing urine takes time. Some people experience low mood, anxiety, or grief, particularly in the first months. Support groups, peer mentors who have lived with the same type of diversion, and mental health professionals can all help. Major urology societies recommend that psychological support be considered a routine part of cystectomy care, not an extra.

Follow-Up and Surveillance

Long-term follow-up after radical cystectomy serves several purposes: watching for cancer recurrence, monitoring kidney function and the diversion, and managing nutritional and metabolic effects.

A typical follow-up schedule includes:

• Clinic visits and physical examination, usually every three to six months in the first two years, then less frequently
• CT imaging of the chest, abdomen, and pelvis at intervals to look for recurrence
• Blood tests including kidney function, electrolytes, and full blood count
• Urine tests, especially if symptoms suggest infection
• Imaging of the upper urinary tract (kidneys and ureters) to look for new urothelial cancers, since the rest of the urinary lining remains at risk
• Vitamin B12 levels in the longer term
• Assessment of the diversion — stoma health, neobladder emptying, or continent channel function

Outlook and What Affects It

Long-term outcomes after radical cystectomy depend on several factors, including:

• The stage of the cancer at surgery (how deeply it had grown and whether lymph nodes were involved)
• Whether the surgical margins were clear of cancer
• The grade and type of bladder cancer
• Response to chemotherapy before or after surgery
• Overall health and the absence of major complications

In general, outcomes are better when the cancer is confined to the bladder and lymph nodes are not involved, and they become more variable when the cancer has extended beyond the bladder wall or into lymph nodes. Your oncology team is the best source of an individualised outlook based on your final pathology, since published statistics are averages across very different populations and cannot predict an individual case.

For many people, radical cystectomy combined with appropriate chemotherapy or immunotherapy offers durable cancer control. Surveillance is essential because recurrences, when they happen, often respond best when found early.

Frequently Asked Questions

How long does radical cystectomy take?

The operation itself usually takes four to eight hours, depending on the approach (open, laparoscopic, or robotic) and the type of urinary diversion. Robotic surgery with internal reconstruction can sometimes take longer than open surgery but with smaller incisions.

Will I need to wear a urine bag for the rest of my life?

It depends on the type of diversion. An ileal conduit involves an external bag worn on the skin. A neobladder allows urination through the urethra without an external bag. A continent cutaneous diversion uses an internal pouch emptied with a catheter, without an external bag. The choice depends on the cancer’s location, your kidney and urethral function, and your preferences.

How long does recovery take?

Most people are in hospital for one to two weeks. Light activities can usually be resumed within four to six weeks, and most people feel substantially recovered by three months. Full adaptation to a new diversion, especially a neobladder, can take six to twelve months or longer.

Will radical cystectomy cure my bladder cancer?

Radical cystectomy offers one of the strongest chances of long-term cancer control for muscle-invasive bladder cancer and selected high-risk non-muscle-invasive disease, especially when combined with chemotherapy where appropriate. The likelihood of cure depends mainly on the stage at surgery, lymph node involvement, and whether the margins are clear. Your surgeon and oncologist can provide an individualised estimate.

How will surgery affect sexual function?

Radical cystectomy can affect sexual function in both men and women. In men, erectile dysfunction is common because nerves near the prostate may be affected; nerve-sparing techniques may help in selected cases. In women, changes to the vagina and surrounding tissues can affect sensation and comfort. Treatments and supportive options are available, and this is an important topic to raise with your team before and after surgery.

Can I return to work and travel?

Most people return to work, travel, and most activities they enjoyed before surgery. The timing depends on the physical demands of your work, the type of diversion, and personal recovery. With some planning, travel — including air travel — is very possible with a stoma, neobladder, or continent diversion.

Is robotic surgery better than open surgery?

Studies suggest robotic radical cystectomy can offer smaller incisions, less blood loss, and a faster early recovery than open surgery, with similar cancer-control outcomes in experienced centres. Open surgery remains an excellent option, especially in advanced disease or where minimally invasive access is difficult. The best approach depends on your specific situation and the surgical team’s expertise.

Do I need chemotherapy as well?

For muscle-invasive bladder cancer, current AUA, EAU, and NCCN guidelines recommend considering cisplatin-based chemotherapy before surgery for people who can tolerate it, because it has been shown to improve survival. Chemotherapy after surgery, and increasingly immunotherapy in selected cases, may also be recommended based on the final pathology. This is decided together with a medical oncologist.

Conclusion

Radical cystectomy is one of the more demanding operations in cancer care — both physically and emotionally — but it is also one of the most established treatments for invasive bladder cancer. Decades of refinement in surgery, anaesthesia, reconstruction, and recovery have made it safer and more predictable than in the past, and modern care emphasises not only removing the cancer but also helping people return to a meaningful daily life.

The decisions involved surgical approach, type of urinary diversion, whether to have chemotherapy or immunotherapy are best made in unhurried conversation with a multidisciplinary team that knows your cancer and you. Preparing well, choosing an experienced centre, and accepting that recovery and adjustment take time are some of the most important things within your control. With the right preparation and support, most people regain independence, return to the activities that matter to them, and live well after surgery.